Lombard Odier Asset Management (Usa) Corp Johnson & Johnson Transaction History

Lombard Odier Asset Management (Usa) Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $2.25 Million - $2.51 Million	-13,959 Reduced 87.47%	2,000 $327,000
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $2.18 Million - $2.41 Million	12,959 Added 431.97%	15,959 $2.83 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $171,265 - $194,495	-1,083 Reduced 26.52%	3,000 $532,000
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $636,662 - $706,399	4,083 New	4,083 $698,000
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $2.51 Million - $2.8 Million	-20,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $2.46 Million - $2.96 Million	20,000 New	20,000 $2.58 Million

4,239

1.7B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Usa) Corp, based on Form 13F filings with the SEC.

Stay updated on Lombard Odier Asset Management (Usa) Corp with notifications on news.